Nephrocare Healt

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
724.75
-13.1 (-1.78%)
BSENSE

Jun 18

BSE+NSE Vol: 82.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

716.10746.05

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

82.94 k (-1.56%) Volume

Shareholding (Mar 2026)

FII

9.94%

Held by 20 FIIs

DII

8.65%

Held by 12 DIIs

Promoter

63.85%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Positive results in Mar 26

  • NET SALES(Q) Highest at Rs 164.33 cr
  • OPERATING PROFIT TO INTEREST(Q) Highest at 17.39 times
  • PAT(Q) Highest at Rs 10.89 cr.
2

With ROE of 6.9, it has a Very Expensive valuation with a 5.6 Price to Book Value

 
3

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 7,272 Cr ()

stock-summary
P/E

94.00

stock-summary
Industry P/E

60

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

6.58

Revenue and Profits:
Net Sales:
266 Cr
(Quarterly Results - Mar 2026)
Net Profit:
30 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.95%
0%
30.95%
6 Months
56.94%
0%
56.94%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Quality Metrics

Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Quality Metrics

Nephrocare Health Services Ltd has been upgraded to a Hold rating with a Mojo Score of 64.0, reflecting significant improvements in its financial trend and quality parameters. The healthcare services company, operating as a small-cap stock, has demonstrated robust quarterly performance and enhanced institutional interest, despite a recent 5.55% dip in its share price. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this rating change as of 20 May 2026.

Read More
Nephrocare Health Services Ltd Quality Grade Upgrade Signals Improved Business Fundamentals

Nephrocare Health Services Ltd Quality Grade Upgrade Signals Improved Business Fundamentals

Nephrocare Health Services Ltd has seen its quality grade upgraded from "Does Not Qualify" to "Good" by MarketsMOJO, reflecting notable improvements in its business fundamentals. Despite a recent 5.55% decline in share price, the healthcare services company demonstrates strengthening operational metrics and financial discipline, positioning it as a noteworthy small-cap in the sector.

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

11-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

10-Jun-2026 | Source : BSE

Pursuant to Reg 30 of SEBI LODR Regulations 2015 we hereby inform that Nephrocare Health Services Philippines Inc. overseas step-down wholly owned subsidiary of the company has acquired a Dialysis centre and has executed Asset Transfer Agreement as per the disclosure annexed herewith.

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

04-Jun-2026 | Source : BSE

Pursuant to Reg 30 of SEBI LODR Regulations 2015 we hereby inform that Nephrocare Health Services Philippines Inc. overseas step-down wholly owned subsidiary of the company has acquired a Dialysis centre and has executed Asset Transfer Agreement as per the disclosure annexed herewith.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.58%
ROCE (avg)
17.70%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
94
Industry P/E
60
Price to Book Value
6.58
EV to EBIT
51.39
EV to EBITDA
30.86
EV to Capital Employed
9.10
EV to Sales
7.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.70%
ROE (Latest)
6.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bearish
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.17%)

FIIs

Held by 20 FIIs (9.94%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "164.33",
          "val2": "160.66",
          "chgp": "2.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.08",
          "val2": "22.86",
          "chgp": "-3.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.27",
          "val2": "3.96",
          "chgp": "-67.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.89",
          "val2": "8.45",
          "chgp": "28.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "14.23%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
164.33
160.66
2.28%
Operating Profit (PBDIT) excl Other Income
22.08
22.86
-3.41%
Interest
1.27
3.96
-67.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.89
8.45
28.88%
Operating Profit Margin (Excl OI)
13.44%
14.23%
-0.79%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Resultsstock-summary
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."